Freedom Capital Markets Downgrades Doximity to Hold, Raises Price Target to $27

Benzinga Newsdesk www.benzinga.com Negative 39.3%

Neg 39.3% Neu 0% Pos 0%

Freedom Capital Markets analyst Gene Mannheimer downgrades Doximity (NYSE:DOCS) from Buy to Hold and raises the price target from $24 to $27.